PIRS News and Press, Pieris Pharmaceuticals Inc. From 11/08/21

BOSTON, MA and PARIS, FRANCE / ACCESSWIRE / November 8, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin ® technology platform for respiratory diseases, cancer, and other ind...

Company To Host an Investor Conference Call on Tuesday, November 2, 2021 at 8:00 AM EDT Dosing completed in part 1a of phase 2a study of PRS-060/AZD1402 Dosing to begin this quarter in phase 2 study of cinrebafusp alfa Received regulatory approval from multiple countries for phase...

Today, we revisit a promising small cap biopharma concern named Pieris Pharmaceuticals for the first time in just over two years. The company has made some progress advancing its pipeline and recently signed a potentially significant collaboration deal with Genentech. A full inves...

BOSTON, MA / ACCESSWIRE / October 26, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer and other indications, today annou...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips I don’t get my investment advice from Robert Kiyosaki, the famous (or infamous) author of the Rich Dad, Poor Dad series of books. However, I can understand his latest cause for concern regarding the supposed global...

Shares of Pieris Pharmaceuticals Inc. (NASDAQ:PIRS) traded at a new 52-week high today of $6.15. Approximately 29.7 million shares have changed hands today, as compared to an average 30-day volume of 1.6 million shares. Over the past year, Pieris Pharmaceuticals Inc. has traded in a rang...

Gainers: ZIVO Bioscience (NASDAQ:ZIVO) +68%, Pieris Pharmaceuticals (NASDAQ:PIRS) +11%, Molecular Templates (NASDAQ:MTEM) +11%, Paratek Pharmaceuticals (NASDAQ:PRTK) +9%, Capricor Therapeutics CAPR +4%. Losers: Kintara Therapeutics KTRA -19%, Oncon...

Are These Penny Stocks Worth Watching This Week? With a three-day weekend at hand, many investors are looking for the best penny stocks to buy. And, this weekend also signals the first full week of September, which could bring about renewed bullish sentiment into the market. While a...

These Penny Stocks May Turn Heads Next Month A great thing about penny stocks and the market, in general, is that there isn’t one right or wrong way to research. Where some traders look at fundamentals and corporate growth, others seek out technical trends and market momentum...

In 2019, tiny Axsome Therapeutics (NASDAQ: AXSM) emerged from micro-cap obscurity to become the best-performing stock in the market, rising by an amazing 3,600% in a year. In 2020, another tiny biotech, Novavax (NASDAQ: NVAX) , came out of nowhere to stomp the stock mark...